Friday, August 02, 2024 10:08:32 AM
"Despite these recent financing activities, FOXO has stated that, based on its current operations, it does not have sufficient capital to fund its operations for at least 12 months from the date of its latest financial statements. The company expects to continue to incur operating losses until it is able to finalize the acquisition of RCHI and generate positive cash flows from the combined operations.
Risks and Challenges
FOXO faces several risks and challenges that could impact its future performance. The company has a history of losses and may not achieve or maintain profitability in the future. It also faces the potential inability to establish or maintain the relationships required to advance its goals or achieve its commercialization and development plans.
Additionally, FOXO’s business is subject to the highly regulated nature of the biotechnology and insurance industries, which could lead to changes in laws and regulations that adversely affect the company’s operations. The enforceability of FOXO’s intellectual property, including its patents, and the potential infringement on the intellectual property rights of others also pose risks.
The company’s continued listing on the NYSE American exchange is also a concern, as FOXO has received notices of noncompliance with certain continued listing standards. While the company is working to regain compliance, there is no assurance that it will ultimately be successful in doing so."
Recent FOXO News
- Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc. • GlobeNewswire Inc. • 09/17/2024 01:00:00 PM
- FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements • GlobeNewswire Inc. • 07/16/2024 08:30:00 PM
- Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements • GlobeNewswire Inc. • 07/01/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:11:32 PM
- FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital • GlobeNewswire Inc. • 06/18/2024 12:30:00 PM
- RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance • GlobeNewswire Inc. • 06/14/2024 09:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/14/2024 09:18:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 06:44:02 PM
- FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. • GlobeNewswire Inc. • 06/14/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 09:07:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/06/2024 08:15:25 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 06/04/2024 07:32:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 07:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 06:20:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 03:04:21 PM
- FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements • GlobeNewswire Inc. • 04/23/2024 09:00:00 PM
- FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global • GlobeNewswire Inc. • 02/14/2024 02:32:34 PM
- FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors • Business Wire • 01/25/2024 10:00:00 PM
- FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions • Business Wire • 01/22/2024 01:30:00 PM
- FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements • Business Wire • 12/19/2023 01:30:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM